Ztalmy

Ztalmy (ganaxolone) is an oral medication prescribed for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This condition primarily affects children and adults with epilepsy. Ganaxolone works by modulating GABA receptors in the brain. It is available in liquid and capsule forms for convenient dosing.

Ganaxolone is used to treat seizures linked to cyclin-dependent kinase-like 5 deficiency disorder (CDD), a rare genetic epilepsy. It is designed to help reduce seizure frequency in patients who have not responded well to other treatments. The medication works by enhancing GABAergic inhibition in the brain. It is suitable for both pediatric and adult patients with this specific epilepsy subtype.

Ganaxolone may help reduce the number and severity of seizures in patients with CDD. Users often report improved seizure control over time with consistent use. Some individuals experience drowsiness or dizziness, especially when starting the medication. These effects are typically temporary and may lessen as the body adjusts.

Store ganaxolone at room temperature away from moisture and direct light. Keep the medication in its original container and out of reach of children. Avoid exposing it to extreme heat or cold. If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double up on doses to catch up.

Ganaxolone can interact with other central nervous system depressants, such as alcohol or sedatives, potentially increasing drowsiness. It may also interact with medications that affect liver enzymes, like certain antidepressants or antifungals. Always inform your healthcare provider about all medications and supplements you are taking. This helps avoid potential interactions.